Rinol-stroche
NDC Package 72988-0041-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Rinol-stroche (flubiprofen) troches is flurbiprofen is used to reduce pain, swelling, and joint stiffness from arthritis. This formulation utilizes a troche delivery system. Marketed by Lydia Co., Ltd., this product is identified by NDC 72988-0041.

Identification & Billing

NDC Package Code
72988-0041-1
Package Description
12 TROCHE in 1 PACKAGE
Product Code
72988-0041
11-Digit Billing Format
72988004101
RxNorm Crosswalk
RxCUI: 389247 - flurbiprofen 8.75 MG Oral Lozenge

Clinical Specifications

Proprietary Name
Rinol-stroche
Non-Proprietary Name
Flubiprofen
Substance Name
Flurbiprofen
Dosage Form
Troche - A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
FLURBIPROFEN 8.75 mg/1
Pharmacologic Class
Usage Information
Flurbiprofen is used to reduce pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

Regulatory & Marketing

Labeler Name
Lydia Co., Ltd.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
11-01-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72988-0041-1 identifies a specific commercial package of 12 troche in 1 package of Rinol-stroche, a human over the counter drug labeled by Lydia Co., Ltd.. This troche is formulated for oral use and contains flurbiprofen as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lydia Co., Ltd. on November 01, 2024. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Flurbiprofen is used to reduce pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

How is this Lydia Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72988004101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
72988-0041-1
11-Digit CMS (5-4-2)
72988-0041-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.